HUMAN LIFE
Non-invasive early cancer detection
Non-invasive early cancer detection Oncoliq
Diagnostics
Oncoliq is transforming the way cancer is detected — one of the leading causes of death worldwide, claiming the lives of more than 9 million people every year. Through the analysis of microRNAs, an unprecedented method, Oncoliq is developing a test capable of detecting up to 50 types of cancer from a single blood sample.
CEO | Marina Simian
Democratizing access to low-cost molecular testing
Democratizing access to low-cost molecular testing Limay Biosciences
Diagnostics
Limay Biosciences has developed an innovative platform capable of identifying virtually any RNA, DNA, or protein. Its applications range from agribusiness and food to both human and animal health. The startup is firmly committed to democratizing access to accurate diagnostic testing for everyone, regardless of where they are, and at a low cost for society.
CEO | Marcelo Kauffman
Non-invasive early detection of cardiovascular and common diseases
Non-invasive early detection of cardiovascular and common diseases MultiplAI Health
Diagnostics
MultiplAI Health is developing an unparalleled, unprecedented biomarker for heart disease. MultiplAI is a preventive healthcare insights company, pioneering RNA-based blood analysis for complex diseases. Its patented technology uses genomic sequencing to digitize a whole blood sample, and advanced Artificial Intelligence to transform it into a detailed, actionable health assessment. Its technology can already detect subclinical diseases up to 35% better than clinical standards. Its precise analysis will enable proactive health management to improve longevity at scale.
CEO | Santiago Miriuka
AI-assisted non-invasive early detection of neurodegenerative diseases
AI-assisted non-invasive early detection of neurodegenerative diseases Tell
Diagnostics
Through a scalable approach, TELL is revolutionizing the methods for accessing brain health diagnoses. Its AI-assisted speech analysis technology provides real-time insights into brain function, enabling pharmaceutical research, healthcare professionals, and individuals to make decisions using any device with a microphone.
CEO | Fernando Johann
Tissue regeneration through microRNAs
Tissue regeneration through microRNAs Dharma BioScience
Therapeutics
Dharma is poised to transform the lives of millions of people suffering from osteoarthritis worldwide. Through a novel, non-invasive approach, it uses precisely delivered modified microRNAs that promote chondrocyte reprogramming, inducing long-term tissue regeneration in a cost-effective way.
CEO | Franco Cescotti
Neural stem cell exosomes for central nervous system disorders
Neural stem cell exosomes for central nervous system disorders Exomas
Therapeutics
Exomas develops formulations based on native exosomes capable of preventing and treating neurodegenerative diseases. It promotes neurogenesis and neuroplasticity by stimulating the differentiation of neural stem cells.
CEO | Hugo Gramajo
Bone regenerator for critical injuries with no therapeutic options
Bone regenerator for critical injuries with no therapeutic options Mestem Bio
Therapeutics
To address the more than 1.7 million critical bone injuries per year with no therapeutic options, Mesenchyal-T is developing stem cell products capable of regenerating bone naturally. With a single intervention, it reduces bone treatment and recovery time, as well as complications.
CEO | Laura Alaniz
Extracellular vesicles to fight inflammatory diseases
Extracellular vesicles to fight inflammatory diseases Libera
Therapeutics
Libera is pioneering the fight against inflammatory diseases through precision medicine, using the functionalization of extracellular vesicles as an innovative method. By tailoring treatments to each patient's individual needs, it offers a solution to address the diverse and complex challenges these conditions pose.
CEO | Matías Vidal
Personalized therapeutic solutions for chronic liver diseases
Personalized therapeutic solutions for chronic liver diseases Spectrum
Therapeutics
Spectrum is pioneering unprecedented therapies to improve the quality of life of patients with acute and chronic liver diseases. By developing a range of tailored molecules, it provides effective therapeutic solutions adapted to each patient.
CEO | Matías Vidal
Personalized skin microbiome detection and recommendation
Personalized skin microbiome detection and recommendation Biotalife
Wellness
Microbiota imbalance contributes to the appearance of both aesthetic and pathological skin alterations, complicating its health. Biotalife is making skin microbiome screening possible, paving the way for precision care that can offer a solution for every need and skin type, regardless of age, sex, or race.
CEO | Vivian Labovsky
Personalized precision medicine for rare and orphan diseases
Personalized precision medicine for rare and orphan diseases Pill.AR
Wellness
Pill.AR seeks to transform the production, access, and consumption of medications and vitamin supplements that help improve the quality of life of millions of people suffering from rare and orphan diseases. The startup has developed a platform of solutions that guarantees traceability, safety, and — equally important — the quality of medications, just as the industry does with standardized drugs. Its decentralized production system ensures precise personalization, making it unique in the sector.
CEO | Enzo Moriconi
Optimizing assisted fertilization
Optimizing assisted fertilization Gameet
MedTech
Gameet understands the difficulties patients face with conventional assisted fertilization techniques, which often have low success rates and create significant emotional and financial burdens. That's why its mission is to transform the world of artificial reproduction using innovative 3D printing technology. By creating personalized, groundbreaking devices, Gameet aims not only to improve the effectiveness of fertility treatments, but also to make the journey to parenthood a more hopeful and accessible experience for everyone.
CEO | Maximiliano Tourmente
ONE HEALTH
Personalized vaccines, better diagnostics
Personalized vaccines, better diagnostics Eureka
One Health
Eureka has developed a patented platform to create cost-effective next-generation nanobiodevices and nanobiomaterials. This unique technology in the market enables the creation of personalized vaccines for humans and animals, the development of novel molecules for diagnostics with improved sensitivity and specificity, and paves the way for breakthroughs in innovative biocatalysts.
CEO | Damián Álvarez Paggi
Complex proteins, made simple and accessible
Complex proteins, made simple and accessible Trebe Biotech
One Health
Trebe Biotech harnesses the previously untapped potential of insects to revolutionize the biotechnology industry. Through its platform, it uses insect larvae — not traditional bioreactors — to produce high-value bioproducts, such as vaccines and recombinant proteins. By reprogramming the natural protein expression capabilities of insects, Trebe offers a simple, smart, and scalable solution to meet global demands in animal health and beyond.
► CEO | Manuel Pacin
PLANET PRESERVATION
Biological leather manufacturing from mycelium
Biological leather manufacturing from mycelium Mycorium Biotech
Biomaterials
The textile industry is estimated to be responsible for the same carbon emissions as the European Union in a year, making it one of the most polluting industries in the world. In response, Mycorium Biotech is dedicated to manufacturing sustainable and eco-friendly materials, focusing on mycelium-based bio-leather. This scalable, cruelty-free approach not only offers an innovative alternative to traditional substitutes for natural leather and eco-leather — both harmful to the environment — but also stands out for being zero waste.
CEO | Agustín Schiavio
Biopigment and biomaterial production for the textile industry
Biopigment and biomaterial production for the textile industry Tintte
Biomaterials
The textile industry is responsible for 20% of global water pollution, mainly due to the dyeing process. Tintte is committed to minimizing this impact by pioneering the use of microorganisms in both pigment production and the dyeing process. It also eliminates the need for toxic additives, supporting the fashion industry in becoming more environmentally responsible. With a holistic approach, it holds a biobank of over 130 microorganisms, making it unique in the international market.
► CEO | Gustavo Freytes
Compostable biopolymer from industrial waste
Compostable biopolymer from industrial waste INMET
Biomaterials
INMET has developed a distinctive technology for producing 100% biodegradable and compostable PHB plastic with a zero environmental footprint. This bioplastic is made from genetically modified bacteria responsible for processing industrial waste. INMET seeks to provide a solution to the environmental crisis caused by plastic pollution.
► CEO | Nicolás Colombres
Nanocarriers to improve crop protection and nutrition
Nanocarriers to improve crop protection and nutrition UNIBAIO
Regenerative Agriculture
Unibaio has developed a novel biodegradable particle that helps plants absorb fertilizers and crop protectors more effectively. This allows farmers to use up to 80% less of these inputs and enables pesticide companies to create better versions of their products. In doing so, companies align with their sustainability commitments while implementing more sustainable global practices. By optimizing resource use and reducing waste, Unibaio is accelerating the transition to a more sustainable future in agriculture.
► CEO | Matías Figliozzi
Biotrained bacteria to increase crop resistance to abiotic stress
Biotrained bacteria to increase crop resistance to abiotic stress M4Life
Regenerative Agriculture
M4LIFE is pioneering the biotraining of microorganisms by creating innovative biological products that synergize with plants to increase their resistance to abiotic stress, such as drought, and improve their nutritional profile. These products also help regenerate saline soils, offering an innovative approach to sustainable agriculture and soil health.
► CEO | Federico Wajnerman
Improving crop yield and stress resistance through photobiology
Improving crop yield and stress resistance through photobiology BEAM Crop Tech
Regenerative Agriculture
BEAM CropTech aims to revolutionize agriculture and food supply for a growing world by improving crop yield and plant resistance to stress. Through extensive research in photobiology, its patented technology optimizes how plants use light — the fundamental signal and energy source for life on Earth.
► CEO | Valeria Arredondon
Biodiversity and pollination optimization through simulated bee dynamics
Biodiversity and pollination optimization through simulated bee dynamics Eiru
Regenerative Agriculture
Eirú integrates agricultural productivity with biodiversity enhancement, leading an innovative approach to pollination optimization by simulating bee dynamics. Its cutting-edge approach bridges agricultural efficiency and biodiversity preservation, setting a new standard in sustainable farming practices.
► CEO | Lucas Alejandro Garibaldi
Emissions reduction for sustainable agriculture
Emissions reduction for sustainable agriculture Soy Green
Regenerative Agriculture
SoyGREEN leads regenerative agriculture with its groundbreaking natural biological solutions tailored to crops. Its innovative products not only reduce greenhouse gas emissions, starting with nitrous oxides, but also provide a roadmap for the progressive reduction of emissions.
► CEO | Daniela Torres
Sustainable mining
Sustainable mining Biometallum
Biomining
BioMetallum is revolutionizing lithium brine mining with its innovative use of the natural power of bacterial strains to capture lithium. Through synthetic biology, it optimizes the lithium uptake capacity of bacteria. This innovative method, the first of its kind in the world, increases productivity and drastically reduces the environmental impact of lithium brine extraction, reshaping the future of sustainable resource mining.
► CEO | Marcos Pacchiele
Development of biofilters with microbes to degrade hydrocarbons
Development of biofilters with microbes to degrade hydrocarbons NotFossil
Bioremediation
The fossil fuel industry generates more than 20 million m³ of wastewater every day. Existing treatment systems require additional costs for companies and are not sustainable. NotFossil develops solutions for complex chemicals in the environment. Its first development is an engineered biofilter with proprietary microbial consortia capable of degrading hydrocarbons, contributing to sustainable operations, cost optimization, and reduced energy consumption.
► CEO | Camila Olivera
BIOTECH TOOLS
Innovation in chemical analysis for research and industry through artificial intelligence and quantum calculations
Innovation in chemical analysis for research and industry through artificial intelligence and quantum calculations Scitrix
Herramientas Biotech
Scitrix develops an advanced computational platform that enables the use of affordable benchtop Nuclear Magnetic Resonance (NMR) equipment to obtain results comparable to the resolution of high-field NMR systems, enabling significant cost reductions in chemical analysis. The platform integrates proprietary algorithms, artificial intelligence, and data analysis tools to automatically generate three-dimensional structures of analytes with high accuracy, democratizing access to advanced NMR capabilities for research and industry. It also operates as a cloud-based API, facilitating integration with multiple providers.
► CEO | María Marta Zanardi
